Cell Therapeutics (CTIC) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Cell Therapeutics (CTIC)

An SI Board Since August 1997

Posts	SubjectMarks	Bans	Symbol
946	45	0	CTIC

Emcee: Regis McConnell	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
546	I bring up economics because paclitaxel is generic. Although CTIC did not really	former_pgs	-	3/7/2005
545	Thank you. Based on precendent what chance do you give them (or this a silly qu	mangery	-	3/7/2005
544	But approval may not be the critical issue. How much premium can the drug comman	Sam Citron	-	3/7/2005
543	>>I thought they already did.>> They have asked for a meeting, but	Icebrg	-	3/7/2005
542	intraday EXEL, just now. edit: just happened to be in this thread, so posted h	scaram(o)uche	-	3/7/2005
541	<i>Try to convince the FDA to amend the SPA for Stellar 2 (?) to allow for	mangery	-	3/7/2005
540	It is not only a matter of alopecia. Not being based on Cremafore is another adv	Icebrg	-	3/7/2005
539	<i>taxol equivalent without hair loss many not be an economically compelli	zeta1961	-	3/7/2005
538	As we had discussed previously, perhaps the only recourse for CTIC is to wait fo	former_pgs	-	3/7/2005
537	Yes, Bianco was extremely tight on giving out any kind of information. Either he	Icebrg	-	3/7/2005
536	Sam: I had a small bet on the company because I wanted a jet like the CEO's	scaram(o)uche	-	3/7/2005
535	<i>It is however impossible to have an opinion on how likely this is, as l	Sam Citron	-	3/7/2005
534	But were they dropping out less from the Xyotax arm due to reduced side-effects	Sam Citron	-	3/7/2005
533	No, there will be no need and there is no money for new trials. CTIC's strat	Icebrg	-	3/7/2005
532	The "official" comment to the failure to achieve superiority, seems to	Icebrg	-	3/7/2005
531	Does CTIC now have to design an entirely new trial in order to prove non-inferio	Sam Citron	-	3/7/2005
530	> It will really be interesting to find out what went wrong with the trial.	CrazyPete	-	3/7/2005
529	I understood, thanks, Jon	tom pope	-	3/7/2005
528	I think a problem unlikely but wanted to point it out as the best case for next	Robohogs	-	3/7/2005
527	Exactly. That is the same conclusion I reached. Furthermore, I contend that any	mangery	-	3/7/2005
526	Mar 60 straddle costs about 4.25. There is not much volume in that strike though	tom pope	-	3/7/2005
525	Below 5 could drive some margin calls. Also, don't these declines usually g	Robohogs	-	3/7/2005
524	SEPR PDUFA is Saturday. Jon	Robohogs	-	3/7/2005
523	Pixantrone appears to be a much safer bet. (I know I am not supposed to write su	Icebrg	-	3/7/2005
522	>>Is pixantrone P2 data contaminated by his virus? Is it reliable?<<	keokalani'nui	-	3/7/2005

Go to reply# or date (mm/dd/yy):